Zhongbo Juli
Chaoyang, Jilinzhongbocapital.com
Overview
Zhongbojuli is a private equity firm founded in 2013. The company has many years of experience in investment consulting for central enterprises, and has super soft investment power.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Suzhou Yige Technology | Jun 2024 | VC Round | Co-investor |
| HemaCell | Dec 2023 | Series A | Lead |
| Innolake Biopharm | Jun 2023 | Series A Extension | Lead |
| Nanjing Immunophage Biomedical Co., Ltd. | Mar 2023 | Series B | Lead |
| Beijing Lingkong Tianxing Technology | Aug 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
